$3.00 -0.02 (-0.66%)
11/25/2009 12:18 PM

Vical, Inc. (VICL)

CAPS Rating: 2 out of 5

The Company researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.

Featured Broker Partners